BRIEF-Moody's cuts Pharmaceutical Product Development CFR to B2

Published Wed, Oct 10 2012 12:56 AM EDTUpdated Fri, Sep 13 2013 4:33 PM EDT

Oct 10 (Reuters) - Pharmaceutical Product Development LLC:

* Moody's downgrades ppd's cfr to b2; new holdco notes rated caa1

1
Ex-Nvidia recruiter’s No. 1 resume red flag: It makes you look like ‘there wasn't a whole lot of effort’
2
Jim Cramer warns against trading Nvidia after blowout quarter
3
Millennials are 'quiet vacationing' rather than asking their boss for PTO
4
Palm Beach housekeepers are making $150,000 a year due to massive demand from the wealthy
5
Here's where the last $6 billion in CHIPS Act semiconductor award money is going

View the full site